- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.01. | Pfizer offers $60m to settle prescriber kickback claims | ||
| 24.01. | Novo Nordisk leaps on new obesity drug data | ||
| 24.01. | Neko Health raises $260m for its bid to transform healthcare | ||
| 24.01. | AstraZeneca reveals $570m investment in Canada | ||
| 24.01. | UnitedHealth names CEO to replace slain Thompson | ||
| 24.01. | Purdue and Sacklers agree new $7.4bn opioid settlement | ||
| 23.01. | US/EU regulators start review of Biogen's high-dose Spinraza | ||
| 23.01. | AMR biotech BioVersys plans to float on Swiss stock exchange | ||
| 23.01. | Date set for RFK Jr's health secretary confirmation hearing | ||
| 23.01. | Study finds big life expectancy deficit in adults with ADHD | ||
| 23.01. | Tris cues up filing for non-opioid pain drug on phase 3 win | ||
| 22.01. | UK kicks off £150m tender process for healthcare AI | ||
| 22.01. | Takeda backs biomarker trial for Crohn's prevention | ||
| 22.01. | Could an AI-powered eye test spot dementia early on? | ||
| 22.01. | J&J's Spravato gets another lift with new FDA approval | ||
| 22.01. | Trump pulls Biden policies on health insurance, drug pricing | ||
| 21.01. | EU approves endometrial, lung cancer drugs from GSK and J&J | ||
| 21.01. | Could OTC Cialis for erectile dysfunction reach the US? | ||
| 21.01. | Two more biotechs join IPO waiting list | ||
| 21.01. | Large study points to benefits - and risks - of GLP-1 drugs | ||
| 21.01. | Experts deplore Trump's order for US to exit from WHO | ||
| 17.01. | Ozempic tops new Medicare price negotiation list | ||
| 17.01. | CDC wants faster testing for bird flu in hospitals | ||
| 17.01. | AI 'can spot cognitive decline linked to menopause' | ||
| 17.01. | Boehringer drug for brain fog in schizophrenia fails trial |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
